Related Experiment Video
Updated: Aug 14, 2025

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Advanced subclinical atherosclerosis: A novel category within the cardiovascular risk continuum with distinct
Michael J Blaha1, Magdy Abdelhamid2, Francesca Santilli3
1Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Blalock 524D1, 600 N. Wolfe Street, Baltimore, MD 21287, USA.
Insights
Guidelines for atherosclerotic cardiovascular disease (ASCVD) risk management need updating. A new "advanced subclinical atherosclerosis" group bridges primary and secondary prevention, improving risk stratification and therapy matching.
Area of Science:
- Cardiology
- Preventive Medicine
- Medical Imaging
Background:
- Current guidelines categorize atherosclerotic cardiovascular disease (ASCVD) risk management into primary and secondary prevention.
- This binary approach conflicts with the continuous biological progression of atherosclerosis.
- Coronary artery calcium (CAC) scoring reveals individuals in primary prevention with risks comparable to secondary prevention subgroups.
Discussion:
- A new clinical group, "advanced subclinical atherosclerosis," is proposed, situated between traditional primary and secondary prevention categories.
- This classification aims to align risk assessment with the biological continuum of atherosclerosis.
- Visualizing plaque burden is key to identifying this intermediate patient population.
Key Insights:
- A novel graphic is introduced to visualize the "advanced subclinical atherosclerosis" group based on plaque burden.
- This tool facilitates better identification of individual cardiovascular risk.
- The graphic supports more effective, risk-based management strategies.
Outlook:
- The proposed framework and visualization tool can enhance clinical decision-making for ASCVD risk management.
- Integrating plaque burden assessment may refine therapeutic intensity matching.
- This approach could lead to more personalized and effective preventive cardiology strategies.
Abstract:
Traditionally, guidelines divide patients into primary and secondary prevention for atherosclerotic cardiovascular disease (ASCVD) risk management. However, the modern understanding of the biological progression of atherosclerosis is inconsistent with this binary approach. Therefore, a new approach demonstrating both atherosclerosis and ASCVD risk as a continuum is needed to give clinicians a framework for better matching risk and intensity of therapy. Advances in coronary imaging have most clearly brought this problem into view, as for example coronary artery calcium (CAC) scoring has shown that some individuals in the primary prevention have equal or higher ASCVD risk as certain subgroups in secondary prevention. This article introduces "advanced subclinical atherosclerosis" as a new and distinct clinical group that sits between the traditional groups of primary and secondary prevention. Importantly, this article also introduces a new graphic to visualize this intermediate population that is explicitly based on plaque burden. The aim of the graphic is both to educate and to allow for better identification of a patient's cardiovascular risk and guide more effective risk-based management.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis IV: Nursing Management

